Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 10/20 | 0.51 |
| ▸ | NPC1 | O15118 | 9/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.51 |
| ▸ | PKM | P14618 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23309702 | 0.90 | ALDH1A1 (0.55) | RAB9ANPC1SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL23309533 | 0.90 | ALDH1A1 (0.43) | CYP1A2RAB9ANPC1SMN1; SMN2PKM | |
| SCHEMBL23309539 | 0.88 | NPC1 (0.52) | CYP1A2RAB9ANPC1SMN1; SMN2POLB | |
| SCHEMBL23309492 | 0.88 | RAB9A (0.45) | CYP1A2RAB9ANPC1SMN1; SMN2PKM | |
| SCHEMBL23309566 | 0.88 | ALDH1A1 (0.41) | CYP1A2RAB9ANPC1SMN1; SMN2PKM | |
| SCHEMBL23309730 | 0.87 | KMT2A (0.47) | RAB9ANPC1SMN1; SMN2MAOBMAOA | |
| SCHEMBL23309711 | 0.86 | GRM4 (0.53) | RAB9ANPC1SMN1; SMN2POLBALDH1A1 | |
| SCHEMBL23309715 | 0.86 | SORT1 (0.46) | RAB9ANPC1SMN1; SMN2KMT2AMAPT | |
| SCHEMBL23309621 | 0.86 | RAB9A (0.50) | CYP1A2RAB9ANPC1SMN1; SMN2POLB | |
| SCHEMBL23309703 | 0.83 | RAB9A (0.51) | RAB9ANPC1SMN1; SMN2MAOBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210120817-A1 | PLANT DISEASE CONTROL AGENT | BROX, ALG1, CTRL | CYP1A2 1133/4885RAB9A 286/4885NPC1 412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.